2013 Pharmacy Track


Download a 29-page Preview Guide (pdf) to the 2013 National Rx Drug Abuse Summit.
 

Corresponding Responsibilities
Tuesday, April 2, 2013, 12:30 pm – 1:45 pm
 Moderator Peter VanPelt, RPH
Associate Director, Corporate Alliance, American Pharmacists Association
 Presenter Joseph T. Rannazzisi
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA)
 Session Description Narcotic painkillers are now the most widely prescribed drugs in the United States, with sales last year of $8.5 billion. While the responsibility for the proper prescribing is upon the prescriber, an additional responsibility rests with the pharmacist who dispenses the prescription. A pharmacist is required to exercise sound professional judgment when making a determination about the legitimacy of a controlled substance prescription, which is not always easy.

In this session, participants will examine methods to determine when and whether the pharmacist is discharging the responsibility to determine whether any given prescription is valid or invalid. Discussions of what to do in the gray areas, what liabilities exist for filling invalid prescriptions, and what penalties await violators of the law will also be included.

 Learning Objectives 1. Identify the legal standard for dispensing medications pursuant to a valid prescription.
2. Explain the legitimate medical purpose standard.
3. List factors the pharmacist should consider in determining whether to dispense medication.
Technologies in Preventing Diversion
Tuesday, April 2, 2013, 2:00 pm – 3:15 pm
 Moderator Dr. Sarah T. Melton
Associate Professor of Pharmacy Practice, Gatton College of Pharmacy Practice
 Presenters Janet Hart
Director, Government Affairs, Rite Aid
 
 
Dr. Michael O’Neil
Professor, Department of Pharmacy Practice, South College School of Pharmacy
 Session Description According to the DEA, armed robberies at pharmacies rose 81 percent between 2006 and 2010 – from 380 to 686 per year. The number of pills stolen in these burglaries grew from 706,000 to 1.3 million. A wave of pharmacy robberies is sweeping the United States as desperate addicts and ruthless dealers turn to violence to feed the nation’s growing hunger for narcotic painkillers. From Redmond, WA, to St. Augustine, FL, criminals are holding pharmacists at gunpoint and escaping with thousands of powerfully addictive pills that can sell for as much as $80 apiece on the street.

Diversion of drugs by healthcare workers poses a considerable challenge for pharmacies. Diversion can lead to significant financial loss and potentially impact patients and staff. In addition, accrediting and regulating agencies require pharmacies to maintain the accountability, security and control of controlled substances, and identify any movement or diversion of drugs in a timely manner. Failure to do so can result in significant accreditation issues and even fines.

This session will educate pharmacists and clinicians on the current technologies in preventing diversion and robberies. Methods such as automated dispensing cabinets (ADC), biometric fingerprint identification, and GPS tracking devices inside pill bottles will be discussed, among others.

 Learning Objectives 1. Evaluate the impact of controlled substance diversion in the hospital setting.
2. Identify primary methods of diversion in the pharmacy and on nursing units.
3. Identify processes to maximize the use of technology in diversion prevention, detection and management.
Risk, Recognize, Resolve: Addiction in the Pharmacy Profession
Tuesday, April 2, 2013, 3:30 pm – 4:45 pm
 Moderator Michael C. Barnes
Attorney, Policy Advisor, DCBA Law & Policy, and Founder and Interim Executive Director, Center for Lawful Access and Abuse Deterrence
 Presenter Brian Fingerson, R.Ph.
President, Kentucky Professionals Recovery Network
 Session Description The National Institute on Drug Abuse (NIDA) states that up to 12 percent of health care professionals have chemical dependencies. Pharmacists work closely every day with patients to ensure their medication is taken in a safe manner. As a frontline dispenser of prescription medication, pharmacists are exposed to greater risks of Rx drug abuse by their patients, colleagues, or themselves.

In this session, attendees will hear an overview of the risk of addiction in healthcare professionals. A study of how addiction is identified in person, responsibilities of professional Boards to the public, and accountability of the recovering professional to their respective regulating or accrediting Board will also be discussed.

 Learning Objectives 1. Identify risk factors for pharmacy professionals that may influence the development of the disease of addiction.
2. Identify the signs and symptoms of the disease of addiction.
3. Describe the resources available to pharmacy professionals when a colleague may need assistance with addiction or substance abuse issues.
4. Describe the structure of accountability added to the recovery person by monitoring with a Pharmacist Recovery Network.
The DEA Regulations
Wednesday, April 3, 2013, 1:30 pm – 2:45 pm
 Moderator LCDR Christopher Jones
Prescription Drug Overdose Team, Division of Unintentional Injury Prevention, Centers for Disease Control and Prevention
 Presenters Chris Angel
President & Co-Founder, Great Lakes Clean Water organization
 
 
Philip P. Burgess, RPh, DPh, MBA
Chairman, Illinois State Board of Pharmacy
 
 
Scott Cassel
Chief Executive Officer and Founder, Product Stewardship Institute
 Session Description SAMHSA’s 2009 National Survey on Drug Use and Health found that more than 70 percent of people who used prescription pain relievers non-medically got them from friends or relatives, while only 5 percent got them from a drug dealer or from the Internet. Therefore, a comprehensive plan to address prescription drug abuse must include proper disposal of unused, unneeded, or expired medications. Providing individuals with a secure and convenient way to dispose of medications will help prevent diversion and abuse, and help to reduce the introduction of drugs into the environment.

Completion of the final rule for the Drug Enforcement Agency, part of the Patient Protection and Affordable Care Act (PPACA), has been sent to the White House for final review. If the rule is released in advance of the Summit, we will discuss the rule and its impact on medical meetings. If it is not released, we will discuss the proposed rule and share insights on the process for finalizing the rule, and what to expect based on stakeholder comments and feedback from Centers for Medicare & Medicaid Services.

 Learning Objectives 1. Identify the basis and effects of the proposed DEA regulations.
2. Lay out the impact of the proposed regulations.
3. Construct a plan of action to implement the DEA regulations and pill take-back programs in the attendee’s community.
Policies and Laws for Pharmacists
Wednesday, April 3, 2013, 3:00 pm – 4:15 pm
 Moderator Peter VanPelt, RPH
Associate Director, Corporate Alliance, American Pharmacists Association
 Presenters Dr. Lynn Lafferty, Pharm.D., MBA, N.D., CNC, CNHP
Assistant Professor at The College of Medicine, Nova Southeastern University
 
Joel Thornbury
President, Kentucky Board of Pharmacy
 Session Description According to the Office of National Drug Control Policy (ONDCP), from 1997 to 2007 the milligram-per-person use of prescription opioids in the U.S. increased from 74 milligrams to 369 milligrams, an increase of 402 percent. In 2000, retail pharmacies dispensed 174 million prescriptions for opioids; by 2009, 257 million prescriptions were dispensed, an increase of 48 percent. In 2010 in Florida, oxycodone caused or contributed to 1,500 deaths — seven deaths per day, according to the DEA.

In this session, participants will hear how New York, Massachusetts, and Florida have approved measures to detect and discontinue suspicious patterns of dispensing. New York’s I-STOP legislation establishes coordinated communication between health care providers and law enforcement to better serve patients. Massachusetts passed legislation restricting pharmacies from dispensing schedule II drugs outside surrounding states. Florida enacted a law banning physicians and clinics from dispensing oxycodone.

 Learning Objectives 1. Describe the relationship between federal law, state law and other regulatory requirements pertaining to diversion.
2. Outline the variables to consider when constructing a strategy for diversion prevention, detection and remediation.
3. Formulate an effective plan of action when diversion is discovered or suspected.